Treatment results in remission for about 85% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis; however, 11–57% of these suffer relapse, which can ...

but at the same time it is extremely important to try to control the disease with a regime that causes as little teratogenicity and harm to the fetus as possible (for drugs used in vasculitis and ...

We learned that abatacept did not reduce the risk of relapse in ANCA-associated vasculitis. There was a lot of efforts in the past years of looking and investigating EGPA, eosinophilic ...

A 79-year-old keen cyclist from Willunga man credits positive thinking with saving him from a rare disease, ANCA vasculitis, after he experienced severe pains while in Thailand. Roger Fabray ...